News

The FDA delivered two notable approvals for RSV immunization, UroGen overcame a negative advisory committee vote to secure an ...
Merck's Enflonsia vaccine for respiratory syncytial virus won approval from the Centers for Disease Control and Prevention's ...
RFK Jr.’s vaccine panel endorsed Merck’s RSV shot for babies, easing fears that his stance might delay rollout.
Kennedy’s controversial panel overhaul met its first test. The result? A major win for public health ahead of RSV season.
U.S. Health Secretary Robert F. Kennedy Jr.'s newly revamped vaccine advisory panel voted on Thursday to recommend use of ...
A CDC advisory panel on Thursday voted 5-2 to recommend the use of a new preventative RSV therapy in babies, Merck’s ...
Enjoy, and see you soon… A fast-growing group of Americans is turning to what many call the “gray market” for obesity ...
An outside group of experts agreed that the CDC should recommend a new antibody drug that offers protection against RSV for ...
Compared with flu vaccine recipients, those given the RSV or shingles vaccine had 18% to 37% lower odds of receiving a ...
The CDC’s Advisory Committee on Immunization Practices (ACIP) has blessed Merck’s new respiratory syncytial virus (RSV) shot ...
The eight new ACIP members met for the first time June 25 after Kennedy fired all 17 original members of the committee June 9 ...